3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum

Molecular Brain Research

Volumn 133, Issue 1, 2005, Pages 131-142

  Adams, David H ^a   Hanson, Glen R ^a   Keefe, Kristen A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Amphetamine; Dynorphin; Enkephalin; In situ hybridization; Neurotensin; Substance P

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; MESSENGER RNA; NEUROMEDIN N; NEUROPEPTIDE; NEUROTENSIN; PREPRODYNORPHIN; PREPROENKEPHALIN; PREPROTACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

3,4-METHYLENEDIOXYAMPHETAMINE; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; AUTORADIOGRAPHY; CORPUS STRIATUM; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; NEUROPEPTIDES; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

EID: 12344309058     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.10.005     Document Type: Article

References (62)

1. D.H. Adams, G.R. Hanson, and K.A. Keefe Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum J. Neurochem. 75 2000 2061 2070
2. D.H. Adams, G.R. Hanson, and K.A. Keefe Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum Neuroscience 102 2001 843 851
3. D.H. Adams, G.R. Hanson, and K.A. Keefe Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix J. Neurochem. 84 2003 87 93
4. M.J. Alexander, M.A. Miller, D.M. Dorsa, B.P. Bullock, R.H. Melloni Jr., P.R. Dobner, and S.E. Leeman Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum Proc. Natl. Acad. Sci. 86 1989 5202 5206
5. C.A. Altar, H. Kim, and J.F. Marshall Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol J. Pharmacol. Exp. Ther. 233 1985 527 538
6. M.G. Bankson, and K.A. Cunningham 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions J. Pharmacol. Exp. Ther. 297 2001 846 852
7. M.E. Benwell, D.J. Balfour, and H.M. Lucchi Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine Psychopharmacology 112 1993 467 474
8. S.J. Boyson, P. McGonigle, and P.B. Molinoff Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain J. Neurosci. 6 1986 3177 3188
9. C.W. Callaway, M.P. Johnson, L.H. Gold, D.E. Nichols, and M.A. Geyer Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists Psychopharmacology 104 1991 293 301
10. J. Camarero, V. Sanchez, E. O'Shea, A.R. Green, and M.I. Colado Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('Ecstasy')-induced dopamine release and free radical formation in the mouse striatum J. Neurochem. 81 2002 961 972
11. M.N. Castel, P. Morino, A. Dagerlind, and T. Hokfelt Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment Eur. J. Neurosci. 6 1994 646 656
12. M.N. Castel, P. Morino, I. Nylander, L. Terenius, and T. Hokfelt Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat Eur. J. Pharmacol. 262 1994 1 10
13. O. Civelli, J. Douglass, A. Goldstein, and E. Herbert Sequence and expression of the rat prodynorphin gene Proc. Natl. Acad. Sci. U. S. A. 82 1985 4291 4295
14. V. Compan, P. Salin, and A. Daszuta Selective effects of partial and severe lesions of the serotonergic systems on met-enkephalin and substance P neurons in rat basal ganglia Brain Res. Mol. Brain Res. 50 1997 246 256
15. D. Crespi, T. Mennini, and M. Gobbi Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine Br. J. Pharmacol. 12 1997 1735 1743
16. K.M. Dewar, T.A. Reader, L. Grondin, and L. Descarries [3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region Synapse 9 1991 14 26
17. A.E. Fleckenstein, H.M. Haughey, R.R. Metzger, J.M. Kokoshka, E.L. Riddle, J.E. Hanson, J.W. Gibb, and G.R. Hanson Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function Eur. J. Pharmacol. 382 1999 45 49
18. D.D. Ginty Calcium regulation of gene expression: isn't that spatial? Neuron 18 1996 183 186
19. V. Gonzalez-Nicolini, and J.F. McGinty NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum Brain Res. 931 2002 41 49
20. W.M. Gray, S.M. Rawls, T.S. Shippenberg, and J.F. McGinty The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum J. Neurochem. 73 1999 1066 1074
21. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") Pharmacol. Rev. 55 2003 463 508
22. P.J. Gresch, and P.D. Walker Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease Neuroscience 93 1999 831 841
23. P.J. Gresch, and P.D. Walker Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat Brain Res. Mol. Brain Res. 70 1999 125 134
24. S. Gygi, J.W. Gibb, and G.R. Hanson Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions J. Pharmacol. Exp. Ther. 270 1994 192 197
25. G.R. Hanson, and K.A. Keefe Dopamine D-1 regulation of caudate neurotensin mRNA in the presence of absence of the nigrostriatal dopamine pathway Brain Res. Mol. Brain Res. 66 1999 111 121
26. Y.L. Hurd, and M. Herkenham Influence of a single injection of cocaine, amphetamine, or GBR 12909 on mRNA expression of striatal neuropeptides Brain Res. Mol. Brain Res. 16 1992 97 104
27. M. Johnson, L.G. Bush, J.W. Gibb, and G.R. Hanson Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems Eur. J. Pharmacol. 193 1991 367 370
28. K.A. Keefe, and C.R. Gerfen D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors J. Comp. Neurol. 367 1996 165 176
29. J.H. Kehne, H.J. Ketteler, T.C. McCloskey, C.K. Sullivan, M.W. Dudley, and C.J. Schmidt Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats Neuropsychopharmacology 15 1996 116 124
30. J.E. Krause, J.M. Chirgwin, M.S. Carter, Z.S. Xu, and A.D. Hershey Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A Proc. Natl. Acad. Sci. 84 1987 881 885
31. A. Mansour, J.H. Meador-Woodruff, Q. Zhou, O. Civelli, H. Akil, and S.J. Watson A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques Neuroscience 46 1992 959 971
32. A.C. McCreary, M.G. Bankson, and K.A. Cunningham Pharmacological studies of the acute and chronic effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/ 1D) receptors J. Pharmacol. Exp. Ther. 290 1999 965 973
33. A.J. McGeorge, and R.L. Faull The organization of the projection from the cerebral cortex to the striatum in the rat Neuroscience 29 1989 503 537
34. K. Merchant, G.R. Hanson, and D. Dorsa Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects J. Pharmacol. Exp. Ther. 269 1994 806 812
35. J.F. Nash, and J. Brodkin Microdialysis studies on 3,4- methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors J. Pharmacol. Exp. Ther. 259 1991 820 825
36. K. Nishijima, A. Kashiwa, A. Hashimoto, H. Iwama, A. Umino, and T. Nishikawa Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo microdialysis Synapse 22 1996 304 312
37. G.G. Nomikos, G. Damsma, D. Wenkstern, and H.C. Fibiger In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis Synapse 6 1990 106 112
38. A. Parent, and L.N. Hazrati Functional anatomy of the basal ganglia I. The cortico-basal ganglia-thalamo-cortical loop Brain Res. Rev. 20 1995 91 127
39. P. Pompei, E. Cavazzuti, D. Martarelli, D. Pediconi, R. Arletti, L. Lucas, and M. Massi Preprotachykinin A gene expression after administration of 3,4-methylenedioxymethamphetamine (Ecstasy) Eur. J. Pharmacol. 450 2002 245 251
40. M. Pompeiano, J.M. Palacios, and G. Mengod Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res. Mol. Brain Res. 23 1994 163 178
41. P. Rompre, and S. Perron Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization Neuropharmacology 39 2000 1880 1892
42. G. Rudnick, and S.C. Wall The molecular mechanism of "Ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc. Natl. Acad. Sci. U. S. A. 89 1992 1817 1821
43. K.E. Sabol, and L.S. Seiden Reserpine attenuates d-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis Brain Res. 806 1998 69 78
44. C.J. Schmidt, C.K. Sullivan, and G.M. Fadayel Blockade of striatal 5-hydroxytryptamine 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4 methylenedioxymethamphetamine J. Neurochem. 62 1994 1382 1389
45. K.M. Skoog, S.T. Cain, and C.B. Nemeroff Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine Neuropharmacology 25 1986 777 782
46. A.J.W. Smith, and J.F. McGinty Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum Brain Res. Mol. Brain Res. 21 1994 359 362
47. J.J. Soghomonian, G. Doucet, and L. Descarries Serotonin innervation in adult rat neostriatum: I. Quantified regional distribution Brain Res. 425 1987 85 100
48. H. Steiner, and C.R. Gerfen Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum J. Neurosci. 13 1993 5066 5081
49. J.P. Tassin, A. Cheramy, G. Blanc, A.M. Thierry, and J. Glowinski Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum: I. Microestimation of [3H] dopamine uptake and dopamine content in microdiscs Brain Res. 107 1976 291 301
50. J.P. Ternaux, F. Hery, S. Bourgoin, J. Adrien, J. Glowinski, and M. Hamon The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat Brain Res. 121 1977 311 326
51. J.A. Tzaferis, and J.F. McGinty Kappa opioid receptor stimulation decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum Brain Res. Mol. Brain Res. 93 2001 27 35
52. P.D. Walker, L.A. Riley, R.P. Hart, and G.M. Jonakait Serotonin regulation of tachykinin biosynthesis in rat neostriatum Brain Res. 546 1991 33 39
53. P.D. Walker, J.G. Capodilupo, W.A. Wolf, and L.R. Carlock Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission Brain Res. 732 1996 25 35
54. S.C. Wall, H. Gu, and G. Rudnick Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux Mol. Pharmacol. 47 1995 544 550
55. J.Q. Wang, and J.F. McGinty Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain J. Pharmacol. Exp. Ther. 273 1995 909 917
56. J.Q. Wang, and J.F. McGinty D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine Synapse 22 1996 114 122
57. R.P. Ward, and D.M. Dorsa Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum J. Comp. Neurol. 370 1996 405 414
58. R. Widmann, and G. Sperk Topographical distribution of amines and major amine metabolites in the rat striatum Brain Res. 367 1996 244 249
59. I. Willuhn, W. Sun, and H. Steiner Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioral context Eur. J. Neurosci. 17 2003 1053 1066
60. B.K. Yamamoto, and L.J. Spanos The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat Eur. J. Pharmacol. 148 1988 195 203
61. B.K. Yamamoto, J.F. Nash, and G.A. Gudelsky Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra J. Pharmacol. Exp. Ther. 273 1995 1063 1070
62. K. Yoshikawa, C. Williams, and S.L. Sabol Rat brain preproenkephalin mRNA. cDNA cloning primary structure, and distribution in the central nervous system J. Biol. Chem. 259 1984 14301 14308